Why CoreWeave plans to buy Core Scientific — and why both stocks are dropping
The $9 billion deal is a play on AI power needs, but one analyst thinks the purchase price undervalues Core Scientific’s business and potential.
17 bargain dividend stocks that are primed for growth — consider this before you buy
Companies passing the screen for low valuations, rapid dividend growth and business-expansion prospects include PepsiCo and Occidental Petroleum.
People are working longer — but are they claiming Social Security later?
Two different measures tell a similar story
The best ways to invest in stock funds
There are plenty of choices. They don’t have to be difficult.
MicroStrategy didn’t buy more bitcoin — for the first time in three months
MicroStrategy made news by not buying bitcoin in the latest week, marking its first pause in three months.
Is Meta’s pricey AI hiring spree worth it? This analyst has doubts.
Meta’s push for top-tier AI talent, which could cost up to $1.4 billion, raises questions about its approach to competing with other companies, a Rosenblatt analyst says.